Foghorn Therapeutics, Inc. (FHTX)
Foghorn Therapeutics Market Cap: 251.09M for Dec. 12, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 7.018M |
| Recursion Pharmaceuticals, Inc. | 2.254B |
| Erasca, Inc. | 1.021B |
| OmniAb, Inc. | 309.50M |
| CEL-SCI Corp. | 19.30M |
Market Cap Related Metrics
| PS Ratio | 11.07 |
| Price | 4.44 |
| Earnings Yield | -26.73% |